Short answer
Tevogen Bio Holdings Inc. (TVGN) filed an 8-K current report with the SEC on April 22, 2026 reporting Item 3.01 (Notice of Delisting). Nasdaq deficiency notices for $50 million listed-securities value and $15 million publicly held shares value.
- This filing includes Item 3.01, an item that often signal trouble.
Tevogen Bio Holdings Inc. 8-K event analysis
AI summary of each reported item and its exhibits
Item 3.01 · Notice of Delisting
- Nasdaq deficiency notices for $50 million listed-securities value and $15 million publicly held shares value
- No immediate trading or listing impact on Nasdaq Global Market
- 180-day cure periods ending October 13 and October 14, 2026
- Compliance requires 10 consecutive business days above the applicable threshold
- Potential Nasdaq Capital Market transfer under evaluation, with no assurance of remediation or continued listing
Generated from the filing text and exhibits; verify against the original. What 8-K item codes mean
Other Tevogen Bio Holdings Inc. 8-K filings
Get the next TVGN 8-K as it lands
Follow TVGN for push alerts, or ask the research agent what this filing means.